Epidemiology and management of Kawasaki disease. - sprookjes - yvandenbroek - TriplyDB

Epidemiology and management of Kawasaki disease.

Epidemiology and management of Kawasaki disease.

http://www.wikidata.org/entity/Q38012529

about

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association Kawasaki Disease: A Clinician's Update Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Kawasaki Disease and Labyrinthitis: An Underdiagnosed Complication.Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea.A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease Profiles of responses of immunological factors to different subtypes of Kawasaki disease.Aspirin in dermatology: Revisited.Kawasaki disease: etiopathogenesis and novel treatment strategies.FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease.Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.An 8-year-old male with 4 days of fever, abdominal pain, and jaundice.

P2860

Q22306356-3DF21D65-20F7-433F-BBBA-04E3EAB0B0F6 Q26998791-69CE429E-2945-4895-AD40-B66ABB277AB8 Q29547691-2513D830-27B8-4436-A291-BEDACDD2B41F Q30238784-0E69B053-BD4F-4EDD-8EED-EFA27EE96730 Q30358570-E451D6FB-DE93-4D01-B222-A4332DD06D79 Q30899913-C6EAB970-ADC4-4BC2-9BCA-32C59014B412 Q33984038-2860124E-6B85-4BF7-837E-C97691357F1B Q34631810-21CA8595-4581-4E82-9314-766A963A20B8 Q35819600-4324E335-3E61-4515-8C30-E1E09E90E5E0 Q36409789-C5152643-3492-4A66-8BD3-D156D8B64A40 Q38945126-FF0938A7-21E0-4A40-89DD-C0FDA29ECFA9 Q40050324-4928763C-DF93-471A-AA71-C3B8302EBA48 Q40086687-DB9BD4CB-74C3-44A5-B195-BE760C7519CA Q40166091-EA4AB8B6-DA9A-4FD4-A9EE-67394A45697D Q40220131-6C724E0E-4648-45B4-9CBB-996751C783F9

P2860

Epidemiology and management of Kawasaki disease.

http://www.wikidata.org/entity/Q38012529

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Epidemiology and management of Kawasaki disease.

@en

type

label

Epidemiology and management of Kawasaki disease.

@en

prefLabel

Epidemiology and management of Kawasaki disease.

@en

P1433

Q38012529-B0C85371-5CBE-4FD3-902D-B232DD4ACFFB

P1476

Q38012529-67D002CA-3B12-42B0-985B-61A437B49E08

P2093

Q38012529-003CDB4A-0AAD-4288-8F42-539CE52EA707

P2860

Q38012529-075B8A5E-8B41-4D94-B659-27B51228AD49

Q38012529-0B51D933-DB0E-4F03-9B60-C5C1CE0C1828

Q38012529-25361E7B-6EB9-4A99-B78E-E90562898E61

Q38012529-276ADC29-98DC-4C98-98F0-F67D2C0027B4

Q38012529-2BBA8F6B-4E5C-437F-9F1D-8BEB46BE20BD

Q38012529-2D7F5842-F697-485E-A8B0-C948AD270DBD

Q38012529-30AB283B-53D3-418E-A9AB-D5242BA819A7

Q38012529-320EA944-10F1-4AAE-A01F-F0DA23EC545A

Q38012529-3DA92A78-189A-4766-AF93-3A1410B1450A

Q38012529-4C9C8BBC-F1C4-4A30-A8F1-35CCB23D8922

P2888

Q38012529-99F7227D-5AC5-460B-ACC7-208A8ECF3BB7

P304

Q38012529-3DF07CDC-5603-429C-A3ED-CAFF9E6C2771

P31

Q38012529-8A9738D5-7A37-410D-A175-735FAEDA6E34

P356

Q38012529-D183A5B2-430E-4F5C-93D8-D66F72E3AE3E

P433

Q38012529-82825A09-ED40-40F9-AC65-FE7756DB7922

P478

Q38012529-0CFFB081-3EED-40E5-A820-D7B6B6D8916E

P50

Q38012529-AA255C9D-DA7B-4A58-9A24-C317ED0A1199

P577

Q38012529-C8DA9581-42BA-4659-A7D9-BB8C33E6E1F6

P6179

Q38012529-CDCBC14A-9EFC-4EE6-984E-D2745CE53004

P698

Q38012529-756762F6-B5E6-44CC-B929-421067391F2F

P356

11631440-000000000-00000

P1433

P1476

Epidemiology and management of Kawasaki disease.

@en

P2093

Nadia J C Luca

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides

Diagnosis, treatment, and long-term management of Kawasaki disease

Infliximab treatment for refractory Kawasaki syndrome

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy

Infections and Kawasaki disease: implications for coronary artery outcome

Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

P2888

11631440-000000000-00000

P304

1029-1038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11631440-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027174153

http://www.w3.org/2001/XMLSchema#string

P698

22621692

http://www.w3.org/2001/XMLSchema#string